LNA Sante

LNA Sante SA Formerly known as Le Noble Age. LNA Sante SA, formerly known as Le Noble Age SA is a France-based company that owns and operates retirement homes and complexes for elderly residents. The Company's residences provide care and assistance for elderly people with a variety of needs, from those with a high level of independence, to those who are completely dependent. LNA Sante SA is also engaged in real estate operations. The Company has residences in France and Belgium. LNA Sante SA operates through its several subsidiaries, including Le Parc de Diane Sarl, Institut Medicalise de Mar Vivo, Gerhome, Residence le Point du Jour and the home healthcare service provider ARAIR Assistance, as well as ARAIR Group's support and training services, among others.
  • TickerLNA
  • ISINFR0004170017
  • ExchangeEuronext Paris
  • SectorHealth Care Equipment & Services
  • CountryFrance

Analysts

For LNA SANTE SA, the environment deterioration entails a downgrade to Neutral

LNA SANTE SA (FR), a company active in the Health Care Providers industry, now shows a lower overall rating. The independent financial analyst theScreener just confirmed the fundamental rating of 2 stars out of 4, as well as the stock market behaviour of the title as moderately risky. However, environmental deterioration penalises the general evaluation, which is downgraded to Neutral. As of the analysis date March 15, 2019, the closing price was EUR 46.45 and its expected value was estimated at EUR 46.37.

Alain William ...
  • Benoit Valleaux
  • Christophe Chaput
  • Christophe-Raphaël Ganet
  • Geoffroy Michalet
  • Jean-François Granjon
  • Jeremy Garnier
  • Michael Foundoukidis
  • Nicolas Thorez
  • Roland Pfaender

ODDO BHF Small & MIDCAP MORNING NEWS - 02/06/2019 Date Performance since listing Date Performance since listing

...

Christophe-Raphaël Ganet

LNA Santé : Satisfactory Q4 2018 revenues – no changes

>Satisfactory Q4 operating revenues: +4.3% l-f-l. - In Q4, LNA Sante booked revenues of € 112.8m, +5.8% and +4.3% l-f-l. LNA Santé’s operating revenues for 2018 came to € 437m, up +5.6% (o/w organic growth of 4.4% and external growth of +1.2%). The retirement home business came to € 259.8m, +3.5%: (the Confort retirement home range had an occupancy rate of over 98% - revenues of € 33.8m, +4% for the full year / the Elégance range booked revenues of € 198.6m, i.e. +3.6...

Alain William ...
  • Benoit Valleaux
  • Christophe Chaput
  • Christophe-Raphaël Ganet
  • Geoffroy Michalet
  • Jean-François Granjon
  • Jeremy Garnier
  • Michael Foundoukidis
  • Nicolas Thorez
  • Roland Pfaender

ODDO BHF Small & MIDCAP MORNING NEWS - 06/02/2019 Date Performance depuis l’entrée Date Performance depuis l’entrée

...

Christophe-Raphaël Ganet

LNA Santé : CA T4 2018 satisfaisant – Pas de changement

>CA Exploitation T4 satisfaisant : +4.3% lfl. - Au T4, LNA Sante a enregistré des revenus de 112.8 M€, +5.8% et +4,3% lfl.Le CA Exploitation de LNA Santé pour l’exercice 2018, s’élève à 437 M€, soit +5.6% (dont 4.4% en croissance organique et +1.2% externe).L’activité Ehpad s’établit à 259.8 M€, +3.5% : (gamme EHPAD Confort TO > 98% - CA de 33.8 M€, +4% sur l'année / gamme EHPAD Elégance CA : 198.6 M€, soit +3.6% par rapport à l’an passé dont organique pour...

Bruno de La Rochebrochard

LNA Santé: Q2 revenue: Ahead our expectation with sustained organic. FY organic now expected over 4%.

Brief Comment - LNA Santé: (BUY, Fair Value EUR68 (+24%)) Q2 revenue: Ahead our expectation with sustained organic. FY organic now expected over 4%.

Christophe-Raphaël Ganet

LNA Santé : Satisfactory Q4 2018 revenues – no changes

>Satisfactory Q4 operating revenues: +4.3% l-f-l. - In Q4, LNA Sante booked revenues of € 112.8m, +5.8% and +4.3% l-f-l. LNA Santé’s operating revenues for 2018 came to € 437m, up +5.6% (o/w organic growth of 4.4% and external growth of +1.2%). The retirement home business came to € 259.8m, +3.5%: (the Confort retirement home range had an occupancy rate of over 98% - revenues of € 33.8m, +4% for the full year / the Elégance range booked revenues of € 198.6m, i.e. +3.6...

Christophe-Raphaël Ganet

LNA Santé : CA T4 2018 satisfaisant – Pas de changement

>CA Exploitation T4 satisfaisant : +4.3% lfl. - Au T4, LNA Sante a enregistré des revenus de 112.8 M€, +5.8% et +4,3% lfl.Le CA Exploitation de LNA Santé pour l’exercice 2018, s’élève à 437 M€, soit +5.6% (dont 4.4% en croissance organique et +1.2% externe).L’activité Ehpad s’établit à 259.8 M€, +3.5% : (gamme EHPAD Confort TO > 98% - CA de 33.8 M€, +4% sur l'année / gamme EHPAD Elégance CA : 198.6 M€, soit +3.6% par rapport à l’an passé dont organique pour...

Christophe-Raphaël Ganet

Eurofins : Armonéa for sale: read-across

>Armonéa: around 9,000 beds - According to French daily Les Echos, Armonéa one of the three main Belgian operators of retirement homes, is up for sale.Armonéa was created in 2008 and reportedly manages around 85 facilities and approximately 9,000 beds (compared with 7,443 beds for Orpea and 10,761 beds for Korian).The group is thought to generate around € 492m in sales (of which € 365m in Belgium) and € 40m in EBITDA (of which € 26m in Belgium). This gives a...

Christophe-Raphaël Ganet

Eurofins : Armonéa à vendre : read-across

>Armonéa : environ 9 000 lits - Selon le quotidien Les Echos, Armonéa, l’un des 3 principaux opérateurs belges de maisons de retraite (maison de repos), créé en 2008, serait en vente.Armonéa gérerait environ 85 établissements et près de 9 000 lits (à comparer à 7 443 lits pour Orpéa et 10 761 lits pour Korian).Le groupe réaliserait près de 492 M€ de CA (dont 365 M€ en Belgique) et 40 M€e d’EBITDA, (dont 26 M€ en Belgique). Soit une marge d’EBITDA de 8,1%.§rc...

Bruno de La Rochebrochard

LNA SANTÉ: Q3 organic revenue growth accelerating. Recently upgraded FY guidance confirmed | BUY | EUR68

LNA SANTÉ - BUY | EUR68(+47%) Q3 organic revenue growth accelerating. Recently upgraded FY guidance confirmed Sustained Q3 revenue with organic again accelerating Confirmation of FY guidance, revised upwards after H1 results

1 director sold

A director at Lna Sante Sa sold 500 shares at 55.178EUR and the significance rating of the trade was 52/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly showing Close periods where trading activity is restricted under listing rules. The names of board memb...

Alain William ...
  • Benoit Valleaux
  • Christophe Chaput
  • Christophe-Raphaël Ganet
  • Geoffroy Michalet
  • Jean-François Granjon
  • Jeremy Garnier
  • Michael Foundoukidis
  • Nicolas Thorez
  • Roland Pfaender

ODDO BHF Small & MIDCAP MORNING NEWS - 02/06/2019 Date Performance since listing Date Performance since listing

...

Alain William ...
  • Benoit Valleaux
  • Christophe Chaput
  • Christophe-Raphaël Ganet
  • Geoffroy Michalet
  • Jean-François Granjon
  • Jeremy Garnier
  • Michael Foundoukidis
  • Nicolas Thorez
  • Roland Pfaender

ODDO BHF Small & MIDCAP MORNING NEWS - 06/02/2019 Date Performance depuis l’entrée Date Performance depuis l’entrée

...

Baptiste Lebacq ...
  • Christophe-Raphaël Ganet
  • Jerôme Bodin

ODDO BHF Small & MIDCAP MORNING NEWS - 11/20/2018

...

Alfred Glaser ...
  • Christophe-Raphaël Ganet
  • Delphine Brault
  • Fatma Agnès Hamdani
  • François Maury
  • Georges Dieng
  • Jean Sassus
  • Johanna Jourdain
  • Matthias Desmarais
  • Olivier Lebrun
  • Pierre Tegner
  • Steven Gould
  • Sven Edelfelt
  • Virginie Rousseau

ODDO BHF SECURITIES MORNING NEWS – DETAILED COMMENTS 11/20/2018

...

Alfred Glaser ...
  • Christophe-Raphaël Ganet
  • Delphine Brault
  • Fatma Agnès Hamdani
  • François Maury
  • Georges Dieng
  • Jean Sassus
  • Johanna Jourdain
  • Matthias Desmarais
  • Olivier Lebrun
  • Pierre Tegner
  • Steven Gould
  • Sven Edelfelt
  • Virginie Rousseau

ODDO BHF SECURITIES MORNING NEWS – COMMENTAIRES DETAILLES 20/11/2018

...

For LNA SANTE SA, the environment deterioration entails a downgrade to Neutral

LNA SANTE SA (FR), a company active in the Health Care Providers industry, now shows a lower overall rating. The independent financial analyst theScreener just confirmed the fundamental rating of 2 stars out of 4, as well as the stock market behaviour of the title as moderately risky. However, environmental deterioration penalises the general evaluation, which is downgraded to Neutral. As of the analysis date March 15, 2019, the closing price was EUR 46.45 and its expected value was estimated at EUR 46.37.

Ford Equity International Rating and Forecast Report

Ford Equity International Research Reports cover 60 countries with over 30,000 stocks traded on international exchanges. A proprietary quantitative system compares each company to its peers on proven measures of business value, growth characteristics, and investor behavior. Ford's three recommendation ratings buy, hold and sell, represent each stock’s return potential relative to its own country market.. The rating reports which are generated each week, include the fundamental details behind each recommendation and reflect the fundamental and price data as of the last trading day of the week...

Jehanne Leroy

Proxy Report - 20/06/2018

Parmi les résolutions proposées par la société, six portent sur la rémunération des dirigeants. Même si les montants indiqués semblentraisonnables, l'absence de communication du bonus annuel total ne nous permet pas de les soutenir (résolutions 10 à 15). En raison de montants demandés trop élevés et de la possibilité d'utilisation en période d'o?re publique, la majorité des autorisations d'augmentation de capital demandées sera refusée (résolutions 18 à 21 et 23 et 24).

ResearchPool Subscriptions

Get the most out of your insights

Get in touch